Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

This study has been completed.
Sponsor:
Collaborators:
Tufts Medical Center
National Cancer Institute (NCI)
Ligand Pharmaceuticals
Information provided by:
Eisai Inc.
ClinicalTrials.gov Identifier:
NCT00211198
First received: September 13, 2005
Last updated: February 29, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)